These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 31230445)

  • 1. Characterization of liver specific promoters in a foamy viral vector pMD09.
    Singh AK; Weber C; Varshney A; Gupta S; Kazim SN; Sanal MG; Rethwilm A; Sarin SK
    Acta Virol; 2019; 63(2):162-168. PubMed ID: 31230445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
    Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
    Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus.
    Cho SY; Lee YJ; Jung SM; Son YM; Shin CG; Kim ET; Kim KD
    J Microbiol Biotechnol; 2024 Apr; 34(4):804-811. PubMed ID: 38379304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy virus transactivation and gene expression.
    Löchelt M
    Curr Top Microbiol Immunol; 2003; 277():27-61. PubMed ID: 12908767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
    Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
    Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the bovine foamy virus miRNA expression cassette and its dumbbell-shaped pri-miRNA.
    Cao W; Heit A; Hotz-Wagenblatt A; Löchelt M
    Virus Genes; 2018 Aug; 54(4):550-560. PubMed ID: 29855776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.
    Sandig V; Löser P; Lieber A; Kay MA; Strauss M
    Gene Ther; 1996 Nov; 3(11):1002-9. PubMed ID: 9044740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of human foamy virus relevant to its development as a vector for gene therapy.
    Hill CL; Bieniasz PD; McClure MO
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2003-2009. PubMed ID: 10466797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and expression of EGFP controlled HBV promoters in eukaryotic cells].
    Xie N; Wang XY; Zhang Q; Lin YY; Lin JS
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):268-71. PubMed ID: 16635295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Vivo Gene Therapy with Foamy Virus Vectors.
    Rajawat YS; Humbert O; Kiem HP
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
    Zhang Y; Huang SZ; Zeng YT
    Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gene expression by human foamy virus and potentials of foamy viral vectors.
    Bodem J; Löchelt M; Yang P; Flügel RM
    Stem Cells; 1997; 15 Suppl 1():141-7. PubMed ID: 9368334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer.
    Chen EQ; Song XQ; Wang YL; Zhou TY; Bai L; Liu L; Liu C; Cheng X; Tang H
    Plasmid; 2011 Mar; 65(2):125-31. PubMed ID: 21108965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foamy viruses--a world apart.
    Delelis O; Lehmann-Che J; Saïb A
    Curr Opin Microbiol; 2004 Aug; 7(4):400-6. PubMed ID: 15358259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.
    Zhang Y; Liu Y; Zhu G; Qiu Y; Peng B; Yin J; Liu W; He X
    J Neurovirol; 2010 Nov; 16(6):419-26. PubMed ID: 20969536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.